Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Moxifloxacin
- Therapeutic area
- Anti-infectives
- Drug class
- Fluoroquinolone antibacterials
- ATC
- J01MA
- Strength
- 400 mg
- Dosage form
- IV infusion
- Pack
- 250 ml vial
- Registration no.
- 046771
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Lixom (Moxifloxacin) is used for
Moxifloxacin is an antibiotic from the fluoroquinolone (quinolone) group. It kills the bacteria that cause an infection. It comes as tablets that a doctor prescribes, can be given through a drip into a vein in hospital, and is also made as eye drops. Because it can cause rare but serious side effects that may last a long time or not go away, UK prescribing information says the tablets should only be used when the antibiotics usually recommended for an infection are not suitable, for example because of resistance, allergy or side effects, or because they did not work.
- Sinus infections caused by bacteria
- Flare-ups of long-term lung disease (COPD), including bronchitis
- Pneumonia caught in the community, when it is not severe
- Mild to moderate pelvic inflammatory disease (infection of the womb and nearby organs)
- A sexually transmitted infection called Mycoplasma genitalium
- Finishing a course of treatment started with moxifloxacin through a drip in hospital, for pneumonia or complicated skin infections
Get medical help straight away if
- Call an ambulance or go to the emergency department for sudden, severe pain in the chest, stomach or back. This can be a sign of a problem with the main blood vessel (aorta).
- Get emergency help for signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, trouble breathing or swallowing, or a widespread rash or hives. This can happen even after the first dose.
- Get emergency help for a fit (seizure), fainting, or any thoughts of harming yourself.
- Stop taking it and contact a doctor straight away for pain or swelling in a tendon (often the ankle or calf) or in a joint. Rest the area. Tendon problems can start during treatment or months after stopping.
Side effects, warnings and interactions for Moxifloxacin
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Moxifloxacin
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Moxifloxacin is right for you and the dose.
- Conjunctivitis (pink eye): For bacterial pink eye when your doctor thinks treatment is needed. Chloramphenicol drops are a common first choice in UK guidance. Fluoroquinolone drops are kept for more severe infection and for contact lens wearers. Ointment is sometimes used at night. They do not help viral or allergic pink eye
- Pneumonia: a single-medicine option for some adults with other illnesses or in hospital
- Tuberculosis (TB): moxifloxacin is part of a 4-month regimen with rifapentine, isoniazid and pyrazinamide for some people with drug-susceptible TB
About Lixom 400 mg IV infusion
Lixom 400 mg IV infusion contains Moxifloxacin 400 mg. It is registered with DRAP by Raazee Therapeutics (Pvt Ltd (registration no. 046771). Its official price is PKR 1,941.50 for a pack of 250 ml vial. This price has applied since 29 July 2026. Lixom is also available as 400 mg tablet. 6 other brands of Moxifloxacin 400 mg (IV infusion) are registered in Pakistan. Compare all brands and prices →
Other strengths of Lixom
All 6 other brands of Moxifloxacin 400 mg infusion in Pakistan
These 6 brands are alternatives (substitutes) to Lixom: each contains Moxifloxacin 400 mg infusion. Ask your doctor or pharmacist before you switch brands.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| GT Mox | GT Pharma Pvt. Ltd | 250mlx1's | PKR 2,170.80 | PKR 2,171 / unit |
| Moxbec | Medisave Pharmaceuticals | 250ml | PKR 1,849.93 | — |
| Moxilab | Medimarker's Laboratories | 250ml vial | PKR 1,846.59 | — |
| Moximax | Lucky Core Industries Limited | 250ml | PKR 1,846.59 | — |
| Ramoxcin | Caliph Pharmaceuticals (Pvt) Ltd | 250ml | PKR 1,706.08 | — |
| Scimox | Scilife Pharma Private Limited | 250ml | PKR 1,158.12 | — |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Lixom, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Raazee Therapeutics (Pvt Ltd., Kasur
- DRAP registration
- 046771
- Phone
- +92 49 2716115
- Website
- https://www.raazee.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (250 ml vial). Current price PKR 1,941.50, effective 29 Jul 2026.
Cite this price history
MedInfoBase. Lixom 400 mg, 250 ml vial: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/lixom-400-mg-046771-250-ml-vial-raazee-therapeutics-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,941.50 | 2026-07-29 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 046771Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.